Dylan Hartley insider trades

Open-market stock purchases and sales by Dylan Hartley, Chief Scientific Officer at OnKure Therapeutics, Inc, from SEC Form 4 filings since Oct 4, 2024.

Recent trades

DateStockTradeValue
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)—
Aug 7, 2026OKUR OnKure Therapeutics, IncSold (not open market)$2.5M
Aug 7, 2026OKUR OnKure Therapeutics, IncBought (not open market)$570K
Apr 1, 2026OKUR OnKure Therapeutics, IncBought (not open market)—

Companies traded

  • OKUR OnKure Therapeutics, Inc: other filings, last Aug 7, 2026

Get free alerts when Dylan Hartley files a new trade →